CONMED Corporation logo

CONMED Corporation

CNMD | NYSE
Chart Builder DCF Calculator
$46.30
+$1.61 (+3.60%)
Sep 22, 2026, 2:43 PM ET · Market open

Market Data

Market Cap
$1.34B
Enterprise Value
$2.14B
Beta
0.91
Average Volume
554.27K
Shares Outstanding (Diluted)
30.12M
Shares Change YoY
-3.02%
Institutional Ownership
N/A
Exchange
NYSE
ISIN
US2074101013

Price Performance

Price Change 1M
-11.7%
Price Change 3M
32.2%
Price Change 6M
20.5%
Price Change YTD
10.3%
Price Change 1Y
-10.6%
Price Change 3Y
-55.8%
Price Change 5Y
-65.6%
1M CAGR (ann.)
-9.0%
1Y CAGR (ann.)
-13.1%
5Y CAGR (ann.)
-17.7%
All-Time CAGR
4.5%

Valuation

PE Ratio
24.16
Forward PE
9.03
PEG Ratio
-0.50
Forward PEG
4.45
PS Ratio
0.98
Forward PS
0.90
PB Ratio
1.29
P/FCF Ratio
9.95
P/Adj. FCF Ratio
11.72
P/OCF Ratio
8.92
EV/Sales
1.56
EV/EBIT
18.87
EV/EBITDA
11.86
EV/FCF
15.88
Earnings Yield
4.1%
FCF Yield
10.1%
Adj. FCF Yield
8.5%

Financial Health

Net Debt
$796.92M
Total Debt
$834.25M
Cash & Short-Term Investments
$37.33M
Total Assets
$2.3B
Current Ratio
1.48
Quick Ratio
0.69
Debt / Equity Ratio
0.80
Debt / EBITDA
4.63
Debt / FCF
6.20
OCF / Debt
0.18
Interest Coverage
4.95
Altman Z-Score
1.89
Piotroski F-Score
7

Margins & Profitability

Gross Profit Margin
54.8%
Operating Profit Margin
10.8%
EBITDA Margin
13.1%
Net Profit Margin
4.1%
FCF Margin
9.8%
Adj. FCF Margin
8.3%
SBC / Revenue
1.5%
SBC Impact (per share)
-15.1%

Returns

Return on Assets
2.5%
Return on Equity
5.5%
Return on Invested Capital
5.0%
Return on Capital Employed
8.0%
Return on Tangible Assets
6.0%

Historical Growth (CAGR)

Revenue CAGR 3Y
6.4%
Revenue CAGR 5Y
7.0%
Revenue CAGR 10Y
6.5%
EPS CAGR 3Y
-13.2%
EPS CAGR 5Y
1.0%
EPS CAGR 10Y
11.6%
FCF CAGR 3Y
103.5%
FCF CAGR 5Y
6.2%
FCF CAGR 10Y
32.6%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
21
EPS Growth Next 3Y
48.9%
Revenue Growth Next 3Y
5.0%
Earnings Date
Nov 3, 2026
EPS Estimate (next Q)
$1
EPS Growth Est (next Q)
-7.4%
Revenue Est (next Q)
$336.25M
Revenue Growth Est (next Q)
-0.5%

Fair Value Estimates

Graham Number
$37.97
Graham Upside
-15.0%
Lynch Fair Value
$9.25
Lynch Upside
-79.3%
Price Target
$37.50
Price Target Upside
-16.1%

Cash Flow

Operating Cash Flow
$150.59M
Free Cash Flow
$134.46M
Adj. Free Cash Flow
$114.18M
FCF Per Share
$4.47
OCF Per Share
$5.01
OCF/S Ratio
11.0%

Income Statement

Revenue
$1.37B
Gross Profit
$752.19M
Operating Income
$148.09M
EBITDA
$179.99M
Net Income
$56.5M
EPS (Diluted)
$1.85
Revenue / Employee
$351.95K
Profit / Employee
$14.49K
Employees
3,900

© 2026 bestshares.com. All rights reserved.